Propanc Biopharma, Inc. (PPCB): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2026-07-17. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

3.31M
As of 2026-06-30
347.44M2011-06-30: 71.92M2012-06-30: 72.71M2013-06-30: 70.63M2014-06-30: 72.68M2015-06-30: 347.44M2016-06-30: 2.91M2017-06-30: 4.55M2018-06-30: 92.8K2019-06-30: 968.0K2020-06-30: 258.1K2021-06-30: 14.06M2022-06-30: 220.4K2023-06-30: 6.03M2024-06-30: 8.0K2025-06-30: 464.5K2026-06-30: 3.31M3.31M
2011-06-30 Shares Outstanding (shares) 2026-06-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2026-06-303.31M+612.8%2026-09-25, Balance as of period end
2025-06-30464.5Kn/c2026-09-25, Balance as of period end
2024-06-308.0K-99.9%2025-09-29, Balance as of period end
2023-06-306.03Mn/m2024-09-30, Balance as of period end
2022-06-30220.4K-98.4%2023-09-28, Balance as of period end
2021-06-3014.06Mn/m2022-09-28, Balance as of period end
2020-06-30258.1K-73.3%2021-09-28, Balance as of period end
2019-06-30968.0Kn/c2020-10-01, Balance as of period end
2018-06-3092.8K-98.0%2019-10-15, Balance as of period end
2017-06-304.55Mn/c2018-09-17, Balance as of period end
2016-06-302.91M-99.2%2017-09-28, Balance as of period end
2015-06-30347.44Mn/c2016-09-28, Balance as of period end
2014-06-3072.68M+2.9%2015-09-30, Balance as of period end
2013-06-3070.63M-2.9%2014-10-14, Balance as of period end
2012-06-3072.71M+1.1%2013-10-15, Balance as of period end
2011-06-3071.92Mn/a2012-10-15, Balance as of period end